The Effects of Sulforaphane in Patients With Biochemical Recurrence of Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2017
At a glance
- Drugs Sulforafan (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 14 Mar 2013 Planned End Date changed from 1 Nov 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.